N-dibenzothiophen-1-yl-N-phenanthren-4-yl-4-phenyldibenzofuran-1-amine
C44H27NOS — CID 176820661
Data last refreshed: (MolForge compound catalog, from PubChem)
About N-dibenzothiophen-1-yl-N-phenanthren-4-yl-4-phenyldibenzofuran-1-amine
N-dibenzothiophen-1-yl-N-phenanthren-4-yl-4-phenyldibenzofuran-1-amine (PubChem CID 176820661) has the molecular formula C44H27NOS and a molecular weight of 617.77 g/mol. Its IUPAC name is N-dibenzothiophen-1-yl-N-phenanthren-4-yl-4-phenyldibenzofuran-1-amine.
Molecular Properties
| Compound Name | N-dibenzothiophen-1-yl-N-phenanthren-4-yl-4-phenyldibenzofuran-1-amine |
|---|---|
| PubChem CID | 176820661 |
| Molecular Formula | C44H27NOS |
| Molecular Weight | 617.77 g/mol |
| Exact Mass | 617.18 |
| IUPAC Name | N-dibenzothiophen-1-yl-N-phenanthren-4-yl-4-phenyldibenzofuran-1-amine |
| SMILES | c1ccc(-c2ccc(N(c3cccc4ccc5ccccc5c34)c3cccc4sc5ccccc5c34)c3c2oc2ccccc23)cc1 |
| InChI | InChI=1S/C44H27NOS/c1-2-12-28(13-3-1)32-26-27-37(43-33-17-6-8-21-38(33)46-44(32)43)45(36-20-11-23-40-42(36)34-18-7-9-22-39(34)47-40)35-19-10-15-30-25-24-29-14-4-5-16-31(29)41(30)35/h1-27H |
| InChIKey | JXFGBVTWOPBNRZ-UHFFFAOYSA-N |
| XLogP | 13.40 |
| TPSA | 16.38 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | 3 |
| Rotatable Bonds | 4 |
| Heavy Atoms | 47 |
| Complexity | — |
Lipinski Rule of Five
2 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 617.77 |
| LogP ≤ 5 | 13.40 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 3 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'Polycyclic_aromatic_hydrocarbon_3', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 176820661 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.